You just read:

Meta-Analysis Using Real-World Data Evaluates Safety Profile of Entyvio® (vedolizumab) in Patients with Moderate to Severe Ulcerative Colitis or Crohn's Disease

News provided by

Takeda Pharmaceutical Company Limited

Nov 01, 2017, 04:30 ET